Ncic Clinical Trials Group

This study tested whether the drug letrozole can help prevent breast cancer from returning in women who have already completed at least 5 years of tamoxifen treatment. Over 5,000 women participated, and the goal was to see if letrozole improves disease-free survival. Letrozole wo…

This study tested whether adding the drug bortezomib to a standard chemotherapy and antibody combination (BCVP-R) could improve outcomes for people with advanced follicular non-Hodgkin lymphoma who had not yet received treatment. A total of 95 participants were enrolled to see ho…